Plain-English translation of NCT07474792 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a new experimental drug called to see if it can help treat moderate to severe plaque psoriasis — a skin condition that causes thick, red, scaly patches. The study will compare three different doses of the medication against a placebo (a dummy treatment with no active ingredients) to find out which dose works best and is safest.
Many people with moderate to severe psoriasis need better treatment options that work well and don't cause major side effects. This study is designed to find the right dose of this new medication that gives patients the most benefit with the fewest problems.
You likely qualify if…
You likely don't qualify if…
If you join, you'll go through a screening period to confirm you qualify, then enter the main treatment period where you'll be randomly assigned to receive either the medication or a placebo. You'll receive your assigned treatment according to the study schedule and visit the clinic for check-ups to see how well it's working and to monitor for any side effects. After the treatment period ends, you'll have follow-up visits to make sure you're doing well.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
United States